MedPath

Lidocaine

FOR EXTERNAL USE ONLY DO NOT USE IN THE EYES Rx Only

Approved
Approval ID

abf864dd-e75f-4a02-8caf-3ad816cd540b

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jun 10, 2022

Manufacturers
FDA

Unit Dose Services

DUNS: 831995316

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Lidocaine

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code50436-0473
Application NumberANDA207810
Product Classification
M
Marketing Category
C73584
G
Generic Name
Lidocaine
Product Specifications
Route of AdministrationTOPICAL
Effective DateJune 26, 2018
FDA Product Classification

INGREDIENTS (3)

POLYETHYLENE GLYCOL 300Inactive
Code: 5655G9Y8AQ
Classification: IACT
LIDOCAINEActive
Quantity: 50 mg in 1 g
Code: 98PI200987
Classification: ACTIB
POLYETHYLENE GLYCOL 1450Inactive
Code: OJ4Z5Z32L4
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Lidocaine - FDA Drug Approval Details